Previous Close | 5.86 |
Open | 11.00 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 5.86 - 5.86 |
52 Week Range | 5.86 - 11.00 |
Volume | |
Avg. Volume | 0 |
Market Cap | 21.873B |
Beta (5Y Monthly) | 1.69 |
PE Ratio (TTM) | 2.39 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.60 (5.49%) |
Ex-Dividend Date | Mar 14, 2024 |
1y Target Est | N/A |
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
TORONTO — Brookfield Corp. reported distributable earnings of US$1.22 billion for the first quarter, up from $1.16 billion in the same quarter last year, as weakness in its asset management arm was offset by strength across the other parts of its business. The Toronto-based alternative asset investment firm, which keeps its books in U.S. dollars, says the result amounted to 77 cents US in distributable earnings per share for the quarter ended March 31, up from 72 cents per share in the first qua
TORONTO — Brookfield Asset Management Ltd. says it earned US$102 million in its first quarter from its stake in the asset management business it owns with Brookfield Corp. The company, which owns a 25 per cent stake in the asset management business that is 75 per cent owned by Brookfield Corp., says its net income in U.S. dollars amounted to 25 cents US per diluted share. The result compared with a profit of US$125 million or 31 cents US per diluted share in the same quarter last year. The asset